Covers the decline of cancer death rates, conventional and targeted anticancer drugs, surgical oncology, radiotherapy, chemotherapy, resistance mechanisms, and the history of targeted drugs and EGFR targeting.
Explores metabolic signaling through glycolysis, the Warburg effect, and glycolytic switches in cancer, emphasizing ATP as the universal energy carrier.
